March 26, 2008 MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) email@example.com Kim AngelastroPublicis Consultants / PR+1 (212) firstname.lastname@example.org AutoPulse Defibrillation Feature Introduced at 2008 EMS Today Real CPR Help, See-Thru CPR, and RescueNet to Be Featured March 26, 2008—Chelmsford, MASS.—ZOLL Medical Corporation (NASDAQ GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, will introduce a new AutoPulse® defibrillation pass-through feature in Booth #722 at the 2008 EMS Today Exhibition March 28-29 at the Baltimore Convention Center in Baltimore. This new feature received FDA 510K clearance on March 19, 2008 and permits defibrillation electrodes to be directly connected to the AutoPulse when treating a patient. ZOLL E Series® defibrillators can then connect to the AutoPulse to facilitate defibrillation. The AutoPulse Non-invasive Cardiac Support Pump is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA). The AutoPulse has been shown to improve survival to discharge in a major study published in the Journal of the American Medical Association (JAMA)*. It also allows EMS professionals to remain safely restrained during patient transport while CPR is performed in the back of a moving ambulance. ZOLL’s entire line of defibrillators features Real CPR Help®, which provides rescuers instantaneous feedback on the rate and depth of their chest compressions. This technology is designed to help rescuers meet the 2005 American Heart Association (AHA) Guidelines, including performing high-quality CPR and capturing data to assist with future CPR training and performance improvement. Now available on the E Series and AED Pro® is ZOLL’s patented See-Thru CPR™ technology, which lets rescuers see a patient’s underlying cardiac rhythm during resuscitation efforts and eliminates the need to stop compressions to see if defibrillation was successful, a significant source of interruptions that reduce CPR effectiveness. “Our focus on incorporating CPR support into our resuscitation products for EMS is validated by recent studies on poor CPR performance in the pre-hospital setting, and the 2005 AHA Guidelines’ focus on the need for effective, high-quality CPR,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. All the CPR data can easily be uploaded to RescueNet® Code Review, which captures, time-synchronizes and consolidates CPR, defibrillator and AutoPulse information into one report in support of quality improvement and training initiatives. RescueNet from subsidiary ZOLL Data Systems® is a suite of integrated EMS software applications that allows users to electronically collect, and review a range of data for evaluating resuscitation performance and reviewing outcomes Additional ZOLL resuscitation products on display include: The ZOLL E Series is designed to meet the specific demands and extreme conditions that professional rescuers face every day. The E Series offers multiple data transmission options to a variety of destinations, including transmission of 12-lead ECGs to hospitals, which 2005 AHA Guidelines recommend for out-of-hospital use to help reduce time to perfusion in S-T segment elevation myocardial infarction (STEMI) patients. ZOLL’s AED Plus® and AED Pro with Real CPR Help instantly allow bystanders and firsts responders see and hear how well they are performing the rate and depth of CPR chest compressions. PocketCPR™ brings ZOLL’s Real CPR Help into a palm-sized device that assists rescuers in the delivery of high-quality (CPR). It coaches rescuers with audio and visual instructions to initiate the critical rescue steps needed for sudden cardiac arrest (SCA), such as checking responsiveness and calling for help, before it provides real-time feedback on the depth and rate of compressions. PocketCPR received FDA clearance as an over-the-counter rescue device in November 2007. ZOLL will also hold a range of activities including: AutoPulse Roundtable Discussion ZOLL is sponsoring a roundtable discussion on AutoPulse on Thursday, March 27th at 5:00 p.m. in Room 316 at the Baltimore Convention Center. This event will feature current users of the AutoPulse, who will share their experiences with this revolutionary device, as well as EMS professionals looking for a broader understanding. The host will be EMS Chief Lloyd R. Carter, City of Baltimore Fire Department, and additional featured speakers will be Robert Orlowski, Business Manager of Twin City Ambulance of Tonawanda, N.Y., and Jerry Overton, Chief Executive Officer of the Richmond Ambulance Authority. CPR Challenge ZOLL invites exhibition attendees to participate in the CPR Challenge using the AED Pro and AED Plus defibrillators in Booth #722. Every hour, ZOLL will award prizes to attendees with the highest percentage of compressions in target (i.e., best rate and depth of chest compressions) that would be effective in helping maintain blood flow to the brain and heart of a cardiac arrest victim. ZOLL St. Bernard ZOLL’s popular rescue dog will also be available for photos with attendees. Participants will be able to download the photo from ZOLL’s website upon their return home. About Sudden Cardiac Arrest The human toll from SCA is alarming with more than 325,000 deaths occurring annually in the United States. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. SCA is an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See Thru CPR™, that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. 2008 marks the 25th anniversary of ZOLL’s resuscitation product development. For more information, visit www.zoll.com. Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on February 5, 2008. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements. Copyright © 2008 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AED Plus, AED Pro, AutoPulse, E Series, LifeBand, RescueNet and Real CPR Help are registered trademarks of ZOLL Medical Corporation. See-Thru CPR and PocketCPR are trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners. * Ong ME, Ornato JP et al. JAMA. 2006;295(22).